Arcmed is a newly-rebranded company that emerged from the collaboration of sister companies Diba, Omnitfit, and Bio-Chem within Halma plc. The company, founded in 2020, focuses on providing technology and supply chain solutions for the design and manufacture of precise fluid handling components for diagnostic and analytical instruments.
Arcmed's mission is to simplify the design and build of these instruments by being more responsive and working collaboratively with customers to develop customized solutions. Their emphasis is on reliability, quality, and scalability. Additionally, the company is committed to improving patient outcomes by addressing the world’s toughest diagnostic and analytical challenges.
Specializing in the biotechnology, manufacturing, and supply chain industries, Arcmed's rebranding aligns with its objective to provide tailored solutions to the market. With its strong foundation and the potential to address critical industry needs, Arcmed presents an exciting investment opportunity in the rapidly evolving biotech and manufacturing sectors.
There is no investment information
No recent news or press coverage available for Arcmed.